100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed nearly $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2005 Research Grants

Cambridge Research Institute
David Tuveson, M.D., Ph.D.
Novel Anti-K-ras Strategies in Ductal Pancreatic Cancer

Georgetown University Medical Center
Anna Riegel, Ph.D.
The Role of the Nuclear Receptor Coactivator AIB1in the Early Preneoplastic Stages of Pancreatic Cancer

Johns Hopkins Medical Institutions
Marcia Canto, M.D.
Screening for Early Pancreatic Neoplasia: A Multi-Center Study

Johns Hopkins Medical Institutions
Elizabeth Jaffee, M.D.
 Functional Genomic Approach to Identify Genes that are Pancreatic Cancer Immune Targets

Johns Hopkins Medical Institutions
Steven D. Leach, M.D.
 High-Throughput, In-Vivo Screening for Novel Pancreatic Cancer Drugs Using the Zebrafish System

Johns Hopkins Medical Institutions
Joshua Mendell, M.D., Ph.D.
The Role of MicroRNAs in the Pathogenesis of Pancreatic Cancer

Technical University of Munich
Roland Schmid, M.D.
Jens T. Svieke, M.D.
The Role of Notch Signaling in Pancreatic Cancer Development

University of Michigan Medical Center
Diane Simeone, M.D.
Pancreatic Cancer Stem Cells

University of Texas M.D. Anderson Cancer Center
George Halder, Ph.D.
A Novel Genetic System to Identify Ideal Cancer Drug Targets in Pancreatic Cancer

University of Utah
Lewis Charles Murtaugh, Ph.D.
Interdependence of Notch and Kras Signaling in Pancreatic Tumorigenesis

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303